Cargando…
Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
Monoclonal antibodies have been approved by the Food and Drug Administration for the treatment of various human cancers. More recently, oligonucleotide aptamers have risen increasing attention for cancer therapy thanks to their low size (efficient tumor penetration) and lack of immunogenicity, even...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770524/ https://www.ncbi.nlm.nih.gov/pubmed/31470510 http://dx.doi.org/10.3390/cancers11091268 |